Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SeraCare™ ACCURUN™ Nucleic Acid Multi-Analyte Positive Controls
Click to view available options
Quantity:
5 x 4 mL
Description
- An independent, easy-to-use, fully-characterized, multi-analyte positive control for multiplex or standard NAT donor screening or patient monitoring
Formulated for use with in vitro diagnostic test methods that detect HIV-1 RNA, HCV RNA and HBV DNA
- ACCURUN 345 Series 150 is prepared by diluting separate stocks of known titers of HIV-1 RNA, HCV RNA and HBV DNA with defibrinated plasma
- Formulated to low concentration levels of HIV-1 RNA, HCV RNA and HBV DNA; challenge assay performance near limit of detection
- Specifically formulated for manual and automated assay platforms to help monitor both assay and instrument integrity
- Human plasma based controls mimic patient samples
- Monitor all aspects of sample testing, from sample lysis and extraction through PCR amplifiction and detection
- Independent controls meet compliance requirements of regulatory agencies and professional organizations
- Liquid, ready-to-use - no reconstitution or special handling required
- Extended shelf life means efficiency for labs, allowing assay performance to be monitored with same lot over an extended period of time
- All SeraCare facilities are ISO 9001 and 13485 certified and comply with cGMP standards
- Routine use of independent controls helps monitor day-to-day test variability, lot-to-lot variability and staff performance
Specifications
Specifications
Certifications/Compliance | IVD, CE, HC |
Detectable Analytes | HIV-1 RNA, HCV RNA, HBV DNA |
Format | Vial |
Type | ACCURUN 345 Multi-analyte Positive Control |
Intended Use | Detect HIV-1 RNA, HCV RNA and HBV DNA, for research use only |
Matrix | Defibrinated Plasma |
Quantity | 5 x 4 mL |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction